Peripheral Arterial Disease Trial, Recruiting NCT04934787 Sponsor: The Hong Kong Polytechnic University Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT04934787
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who had a stroke at least 6 months ago
  • People who have enough mental clarity to follow simple instructions and understand the study — this is measured by a short memory and thinking test, with a score above 21 required
  • People who have mild to moderate weakness or movement difficulty in the affected leg, including foot drop, but are still able to stand and walk without another person physically helping them
  • People whose lower limb movement scores fall below 20 on a standard stroke movement assessment (called the Fugl-Meyer Assessment) (confirm with trial site)
  • People who score 4 or above on a walking ability scale (called the Functional Ambulatory Category), indicating some independent walking ability (confirm with trial site)
  • People who score 40 or above on a balance assessment (called the Berg Balance Scale) (confirm with trial site)

Who may not be able to join:

  • People who have severe muscle stiffness (spasticity) in the ankle joint, measured above 3 on a standard stiffness scale (confirm with trial site)
  • People who are already taking part in other rehabilitation programs or treatments for the affected leg at the same time as the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 34003206

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Hong Kong Polytechnic University
Registry
ClinicalTrials.gov
Start date
1 July 2021
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in Fugl-Meyer Assessment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov